2018•国际医药卫生导报Requires access

Clinical observation on N-acetyl cysteine combined with prednisone in the treatment of idiopathic pulmonary fibrosis

Shun Liu

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of N-acetyl cysteine in the treatment of idiopathic pulmonary fibrosis. Methods 60 cases of patients with idiopathic pulmonary fibrosis in the outpatient of our hospital were randomly divided into control group and observation group, 30 patients in each group. The control group was treated with prednisone, and the observation group was treated with N-acetyl cysteine combined with prednisone. After 6 months of treatment, compared the clinical efficacy of the two groups. Results After treatment, the level of PaO2 and diffusion capacity of carbon monoxide of the observation group [(10.3±0.72) mmHg, (73.6±4.7) ml•kPa-1/s] were better than those of the control group, the total effective rate of the observation group was better than that of the control group [90.0% (27/30) vs. 60.0% (18/30)], with statistically significant differences (P<0.05). Conclusion N-acetyl cysteine combined with prednisone has significant clinical effect in the treatment of idiopathic pulmonary fibrosis, can effectively improve the adverse symptoms of patients, worthy of clinical promotion. Key words: N-acetyl cysteine; Idiopathic pulmonary fibrosis; Clinical treatment

About this research paper

What this paper is about

Objective To observe the clinical effect of N-acetyl cysteine in the treatment of idiopathic pulmonary fibrosis. Methods 60 cases of patients with idiopathic pulmonary fibrosis in the outpatient of our hospital were randomly divided into control group and observation group, 30 patients in each group. The control group was treated with prednisone, and the observation group was treated with N-acetyl cysteine combined with prednisone. After 6 months of treatment, compared the clinical efficacy of the two groups. Results After treatment, the level of PaO2 and diffusion capacity of carbon monoxide of the observation group [(10.3±0.72) mmHg, (73.6±4.7) ml•kPa-1/s] were better than those of the control group, the total effective rate of the observation group was better than that of the control group [90.0% (27/30) vs. 60.0% (18/30)], with statistically significant differences (P<0.05). Conclusion N-acetyl cysteine combined with prednisone has significant clinical effect in the treatment of idiopathic pulmonary fibrosis, can effectively improve the adverse symptoms of patients, worthy of clinical promotion. Key words: N-acetyl cysteine; Idiopathic pulmonary fibrosis; Clinical treatment

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of N-acetyl cysteine in the treatment of idiopathic pulmonary fibrosis. Methods 60 cases of patients with idiopathic pulmonary fibrosis in the outpatient of our hospital were randomly divided into control group and observation group, 30 patients in each group. The control group was treated with prednisone, and the observation group was treated with N-acetyl cysteine combined with prednisone. After 6 months of treatment, compared the clinical efficacy of the two groups. Results After treatment, the level of PaO2 and diffusion capacity of carbon monoxide of the observation group [(10.3±0.72) mmHg, (73.6±4.7) ml•kPa-1/s] were better than those of the control group, the total effective rate of the observation group was better than that of the control group [90.0% (27/30) vs. 60.0% (18/30)], with statistically significant differences (P<0.05). Conclusion N-acetyl cysteine combined with prednisone has significant clinical effect in the treatment of idiopathic pulmonary fibrosis, can effectively improve the adverse symptoms of patients, worthy of clinical promotion. Key words: N-acetyl cysteine; Idiopathic pulmonary fibrosis; Clinical treatment

Key concepts: Prednisone, Idiopathic pulmonary fibrosis, Medicine, Gastroenterology, Pulmonary fibrosis, Internal medicine, Pulmonary function testing, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on N-acetyl cysteine combined with prednisone in the treatment of idiopathic pulmonary fibrosis — Research Paper | ScholarLens